Summary
In the present experiments we investigated endothelin (ET) receptors in the human coronary artery, and in ventricular and atrial muscle using quantitative receptor autoradiography. Displacement of [125I]Sf6b (Sarafotoxin S6b) (30 pM)- and [125I]ET-1 (30 pM)-labeled binding sites was studied using ET-1, the ETA receptor selective ligand BQ-123 (cyclo[D-Asp-L-Pro-D Val-L-Leu-D-Trp-]), and the ETB receptor selective ligand [Ala1,3,11,15]ET-1.
Specific binding was more dense in atrium and coronary artery (relative optical density (r.o.d.): 0.14±0.01 and 0.16±0.01, respectively) than in ventricular muscle (r.o.d.: 0.10±0.01). In the coronary artery, binding was especially dense in the media. ET-1 displaced [125I]ET-1 and [125I]Sf6b monophasically in atrium, ventricle and coronary artery. [Ala1,3,11,15]ET 1 and BQ-123 displaced [125I]ET-1 and [125I]Sf6b-labeled sites biphasically in the ventricle and in the atrium. In the human coronary artery, [Ala1,3,11,15]ET-1 and BQ-123 displaced [125I]ET-1-labeled sites monophasically (pIC50): ET-1 (9.72±0.12) > BQ-123 (6.84±0.08) > [Ala1,3,11,15]ET-1 (6.40±0.12). In contrast, [Ala1,3,11,15]ET-1 and BQ-123 displaced [125I] Sf6b-labeled coronary artery sites biphasically (high affinity pIC50: BQ-123, 9.03±0.25;[Ala1,3,11,15]ET-1, 8.40±0.14; low affinity pIC50: BQ-123, 7.24±0.14; [Ala1,3,11,15]ET-1, 6.99±0.09).
These data indicate that both [125I]ET-1 and [125I] Sf6b-labeled ETA and ETB binding sites in human ventricular and atrial muscle. In the human coronary artery, both radioligands labeled ETA binding sites, but [125I] Sf6b also labeled a non-ETA, non-ETB binding site with relatively high affinity for both BQ-123 and [Ala1,3,11,15] ET-1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730–732
Bax WA, Bruinvels AT, Saxena PR, Hoyer D (1993) Endothelin receptors in human cardiac tissue; a quantitative autoradiographic analysis. Br J Pharmacol 108:112P (abstract)
Brodde O-E, Bals S, Broede A, Kunde K, Schdfer E, Zerkowski H-R (1992) Receptor systems mediating positive inotropic effect in isolated human right atrium. Br J Pharmacol 105:108P (abstract)
Chester AH, Dashwood MR, Clarke JG, Larkin SW, Davies GJ, Tadjkarimi S, Maseri A, Yacoub MH (1989) Influence of endothelin on human coronary arteries and localization of its binding sites. Am J Cardiol 63:1395–1398
Davenport AP, Nunez DJ, Hall JA, Kaumann AJ, Brown MJ (1989) Autoradiographical localization of binding sites for porcine [125I]Endothelin-1 in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol 13[suppl 5]:S166-S170
Davenport AP, Molenaar P, Kuc RE (1992) BQ123 and BQ2030 reveal endothelin ETA and ETB receptor sub-types in human cardiac ventricle and rat cerebellum. Br J Pharmacol 107:304P (abstract)
De Lean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102
De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797–9800
Fan THM, Himura Y, Hood WB, Liang C-S (1992) Endothelin receptors in the failing myocardium. Circulation 86[suppl I]:I768 (abstract)
Fukuda N, Izumi Y, Soma M, Watanabe Y, Watanabe M, Hatano M, Sakuma I, Yasuda H (1990) L-NG-monomethyl arginine inhibits the vasodilating effects of low dose of endothelin-3 on rat mesenteric arteries. Biochem Biophys Res Commun 167:739–745
Fukuroda T, Nishikibe M, Ohta Y, Ihara M, Yano M, Ishikawa K, Fukami T, Ikemoto F (1992) Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ153. Life Sci, Lett 50:PL107-PL112
Harrison VJ, Randriantsoa A, Schoeffter P (1992) Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br J Pharmacol 105:511–513
Hemsén A, Franco-Cereceda A, Matran R, Rudehill A, Lundberg JM (1990) Occurrence, specific binding sites and functional effect of endothelin in human cardiopulmonary tissue. Eur J Pharmacol 191:319–328
Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsudicha S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M (1991) Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50:247–255
Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T (1988a) Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 255:H970-H973
Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T (1988b) Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflügers Arch 413:108–110
Jahnel U, Rupp J, Ertl R, Nawrath H (1992) Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn-Schmiedeberg's Arch Pharmacol 346:482–485
Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1991) A 5-HT4-like receptor in human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 344:150–159
Komuro I, Kurihara H, Sagiyama T, Takaku F, Yazaki Y (1988) Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238:249–252
Kitayoshi T, Watanabe T, Shimamoto N (1989) Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo. Eur J Pharmacol 166:519–522
Miller RC, Pelton JT, Huggins JP (1993) Endothelins — from receptors to medicine. Trends Pharmacol Sci 14:54–60
Molenaar P, Kuc RE, Davenport AP (1992) Characterization of two new ETB selective radioligands, [125]BQ3020 and [125I] [Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol 107:637–639
Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham GA, Davenport AP (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72:526–538
Moody CJ, Dashwood MR, Sykes RM, Chester M, Jones SM, Yacoub MH, Harding SE (1990) Functional and autoradiographic evidence for endothelin 1 receptors on human and rat cardiac myocytes; Comparison with single smooth muscle cells. Circ Res 67:764–769
Moravec CS, Reynolds EE, Stewart RW, Bond M (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159:14–18
Nakamichi K, Ihara M, Kobayashi M, Saeki T, Ishikawa K, Yano M (1992) Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1. Biochem Biophys Res Commun 182:144–150
Nambi P, Pullen M, Wu H-L, Aiyar N, Ohlstein EH, Edwards RM (1992) Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131:1081–1086
Ohlstein EH, Arleth A, Bryan H, Elliot JD, Sung CP (1992) The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol 225:347–350.
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732–735
Saeki T, Ihara M, Fukuroda T, Yamagiwa M, Yano M (1991) [1,3,11,15]Endothelin-1 analogs with ETB agonistic activity. Biochem Biophys Res Commun 179:286–292
Schoemaker RG, Du XY, Bax WA, Saxena PR (1992a) 5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 346:486–489
Schoemaker RG, Du XY, Bax WA, Bos E, Saxena PR (1992b) 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol 230:103–105
Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC, Brown JH, Chien KR (1990) Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J Biol Chem 265:20555–20562
Sumner MJ, Cannon TR, Mundin JW, White DG, Watts IS (1992) Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction. Br J Pharmacol 107:858–860
Takanashi M, Endoh M (1991) Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium. Am J Physiol 261:H611-H619
Williams DL, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV (1991) Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556–561
Wright CE, Fozard JR (1988) Regional vasodilatation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 155:201–203
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Author information
Authors and Affiliations
Additional information
Correspondence to W. A. Bax, at the above address
Rights and permissions
About this article
Cite this article
Bax, W.A., Bruinvels, A.T., van Suylen, RJ. et al. Endothelin receptors in the human coronary artery, ventricle and atrium. Naunyn-Schmiedeberg's Arch Pharmacol 348, 403–410 (1993). https://doi.org/10.1007/BF00171340
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171340